SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001341004-20-000055
Filing Date
2020-02-13
Accepted
2020-02-13 16:05:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13 G/A - AMENDMENT 1 sc13g-a1.htm SC 13G/A 68348
2 EXHIBIT 1 ex99-1.htm EX-99.1 5616
  Complete submission text file 0001341004-20-000055.txt   75467
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filed by) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89674 | Film No.: 20610391
SIC: 2836 Biological Products, (No Diagnostic Substances)